2017 Volume 17 Issue 4 Pages 220-225
Type 2 diabetes impairs the quality of life of patients because of the micro-and macro-angiopathic complications. Furthermore, the augmentation of medical costs due to the recent increase of the disease poses a serious problem of national importance. Therefore, we have analyzed the relationship between several clinical indicators and medical costs.
A total of 798 patients with type 2 diabetes who had more than 1 year of outpatient history at Aso Iizuka Hospital from January 2006 to March 2013 were enrolled. The relationship between the clinical indicators and the monthly average medical costs (MAMC) was analyzed using the database developed from electronic medical records and detailed statements of remuneration for treatment. Patients included 420 men and 378 women whose ages ranged from 17 to 93 years (63.1±12.9 years). As a result, the blood levels of glucose and glycoalbumin positively correlated to MAMC. On the other hand, the estimated glomerular filtration rate (eGFR) negatively correlated to MAMC. MAMC revealed gradual increase in accordance with the elevation of GFR stages. Noteworthy, there were no significant differences of MAMC between G1, G2, G3a and G3b, but MAMC showed significant differences between G3b, G4 and G5.
The diabetic nephropathy should be strictly controlled at G3a stage in order to optimize MAMC in the treatment of type 2 diabetes.
